Ian Thompson Jr., MD – MEDICAL ADVISOR
Dr. Thompson is the President of Christus Santa Rosa Hospital and former Director of the UT Health San Antonio Cancer Therapy & Research Center. Dr. Thompson is a urologic oncologist who specializes in prevention, early detection, and treatment of prostate and other urologic cancers, including cancers of the kidney, bladder and testis. A trustee of the American Board of Urology, chairman of the Early Detection Research Network of the National Cancer Institute, and chair of the Genitourinary Cancer Committee of the Southwest Oncology Group, one of the largest cancer treatment trial organizations in the world.
Michael Liss, MD – PRINCIPLE INVESTIGATOR PROSTATE CANCER TRIAL
Dr. Liss is a practicing physician at UT Health San Antonio where he specializes in cancer of the genitourinary system including kidney cancer and prostate cancer. He is the site principal investigator for SWOG, formerly the Southwest Oncology Group, one of the largest cooperative clinical trial groups in the world. He also serves as the medical director of clinical research at University Hospital. Dr. Liss is an active member of the cancer center’s genetics and high risk cancer screening clinic focusing on patients at high risk for kidney and prostate cancer. Dr. Liss graduated with honors from the Medical School of Wisconsin and completed training at the University of California, Irvine and a fellowship in urologic oncology at the University of California, San Diego. He holds a Masters of Applied Science in Clinical Trials (MAS).
Will Quirk, JD – INTELLECTUAL PROPERTY AND REGULATORY AFFAIRS
Will is a partner and the head of the Intellectual Property Group at Rosenthal Pauerstein Sandoloski Agather LLP, Attorneys at Law. Prior to joining Rosenthal Pauerstein, Mr. Quirk worked at Kinetic Concepts where he served as Associate General Counsel, Chief I.P. Counsel and Director, Regulatory Affairs.